Officials from the World Health Organization (WHO) today announced that the large global treatment trial that it is leading will drop the hydroxychloroquine arm and that it is taking steps to update its clinical guidance based on new promising treatment findings of the steroid dexamethasone in severely ill patients.The global COVID-19 total grew to 8,278,155 cases today, and 446,202 people have died from their illnesses, according to the Johns Hopkins online dashboard.SOLIDARITY trial stops hydroxychloroquine armAt a World Health Organization (WHO) media briefing today, Ana Maria Henao Restrepo, MD, unit head of the WHO's research and development blueprint, said review board of the SOLIDARITY trial—a large international randomized